Cargando…

MEFV mutations in systemic JIA

Detalles Bibliográficos
Autores principales:	Aktay Ayaz, N, Bilginer, Y, Yilmaz, E, Ergüven, M, Topaloglu, R, Bakkaloglu, A, Ozen, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334067/ http://dx.doi.org/10.1186/1546-0096-6-S1-P26

Ejemplares similares

Does unity of Familial Mediterranean fever with juvenile idiopathic arthritis affect the outcome?
por: Topaloglu, R, et al.
Publicado: (2008)

Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
por: Polat, Adem, et al.
Publicado: (2011)

A safe protocol for tuberculin test assessment in a country where BCG vaccination is mandatory
por: Ayaz, N Aktay, et al.
Publicado: (2008)

Behcet Disease: treatment of vascular involvement in children
por: Bilginer, Y, et al.
Publicado: (2008)

Features of enthesitis related arthritis in Turkish children
por: Akkus, K, et al.
Publicado: (2008)

PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation
por: Aktay Ayaz, N, et al.
Publicado: (2013)

A case of chronic recurrent multifocal osteomyelýtýs successfully treated with etanercept
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Musculoskeletal sonography in juvenile systemic lupus erythematosus
por: Demirkaya, E, et al.
Publicado: (2008)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

Differences in the severity of the phenotype of children and adolescents with Familial Mediterranean Fever residing in Turkey and Germany
por: Ayaz, N Aktay, et al.
Publicado: (2008)

Genetic analysis of MEFV mutation negative familial Mediterranean fever for non-MEFV mutations is rarely effective
por: Ben-Zvi, I, et al.
Publicado: (2015)

Assessment of children presenting with rheumatic complaints to a tertiary center in Turkey: differences in an Eastern Mediterranean population
por: Bircan Cavkaytar, Ö, et al.
Publicado: (2008)

A novel therapeutic approach for macrophage actıvatıon syndrome due to SoJIA
por: Ayaz, Nuray Aktay, et al.
Publicado: (2011)

Profile of cytokines, growth factors and chemokines during attacks of FMF
por: Bilginer, Y, et al.
Publicado: (2008)

MEFV gene mutation distrubution in Azerbaijan population
por: Berdeli, A, et al.
Publicado: (2015)

PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey
por: Kara Eroglu, F, et al.
Publicado: (2013)

MEFV mutations - therapeutic guides or red herrings?
por: Warrier, K, et al.
Publicado: (2015)

Acute phase reactants in the follow-up of patients with FMF
por: Arıcı, ZS, et al.
Publicado: (2015)

MEFV gene methylation pattern analysis in familial Mediterranean fever patients with altered expression levels
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

MEFV mutations in Iranian children with systemic onset juvenile idiopathic arthritis
por: Farivar, Shirin, et al.
Publicado: (2014)

Prevalence of MEFV gene mutations in apparently healthy Slovenian and Macedonian population
por: Debeljak, M, et al.
Publicado: (2011)

Genotype -phenotype correlation of MEFV mutations in Eastern / Central European population
por: Toplak, N, et al.
Publicado: (2015)

A pilot study for genome wide association study (GWAS) in patients with juvenile idiopathic arthritis (JIA) and their parents
por: Ozen, Seza, et al.
Publicado: (2011)

Clinical and subclinical features and MEFV mutation distribution in of FMF patients’ siblings
por: Gunduz, Z, et al.
Publicado: (2015)

MEFV mutation carriage as possible predisposition factor for the development of Post Pericardiotomy Syndrome (PPS)
por: Dechtman, ID, et al.
Publicado: (2015)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Turkish Pediatric Rheumatology Society consensus statements on systemic onset juvenile idiopathic arthritis in Turkey
por: Sozeri, B, et al.
Publicado: (2015)

PReS-FINAL-2209: MEFV gene mutations in central and south-eastern European countries
por: Perko, D, et al.
Publicado: (2013)

Determing an “autoimmune” phenotype in systemic JIA
por: Fischer, N, et al.
Publicado: (2011)

A case with febrile attacks and vasculopathy associated with ADA2 and MEFV gene mutations
por: Ozdogan, H, et al.
Publicado: (2015)

Dutch type periodic fever in a Turkish infant also having MEFV mutation
por: Makay, B, et al.
Publicado: (2008)

Sweet's syndrome in a patient with compound heterozygous mutations in the Mediterranean fever gene (MEFV)
por: Michelson, M, et al.
Publicado: (2015)

The clinical spectrum of 94 French patients carrying a single mutated MEFV allele
por: Koné-Paut, I, et al.
Publicado: (2008)

P01-048 – Systemic onset JIA with coronary artery dilation
por: Ayaz, N Aktay, et al.
Publicado: (2013)

Impact of MEFV genotype in Caucasian children with periodic fever
por: Federici, Silvia, et al.
Publicado: (2011)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

Neuroblastoma versus systemic JIA – a diagnostic dilemma
por: Scalzi, Lisabeth, et al.
Publicado: (2012)

The frequency of MEFV gene variations in Adult-onset Still's disease and Gout
por: Ugurlu, S, et al.
Publicado: (2015)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Mesenchymal stem cells and JIA
por: Swart, JF, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rqj29nc9al147f23vutttp8st7